(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
Phyllodes Tumor
Brachytherapy
Chemoprevention
Cytotoxic
Multimodality Therapy
Radiotherapy
Palpation
African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
Cyclophosphamide
Flow Cytometry
Cytostatic
Cyst
Apoptosis
Chemotherapy
Self-examination
Dose Dense Therapy
Antiemetics
Estrogen/Estradiol
EGFR
Absolute Risk
Dimpling
Morphea
Ayurveda
Ovarian Suppression
Lymphoscintigraphy
Breast cancer is the leading cause of death in women between the ages of 40 and 55
BRCA Gene
MRI
Alcohol intake of more than two drinks per day is a risk factor for breast cancer
Calcifications
Intraductal Papilloma
Triple +/- Breast Cancer
Bevacizumab
Kappa Epsilon
RAD
Hormone Replacement Therapy
Mastodynia
SERM
Anastrozole
Paclitaxel
Guaranteed Renewable Insurance
Raloxifene
BI-RADS
BOCA
Oligometastases
CDK4/6 Inhibitors
Capecitabine
Definitive Surgery
Docetaxel
Germline Mutation
ER +/-
Breast Cancer
For every 1,000 screening mammograms performed, about five breast cancers are detected.
Megestrol Acetate
Immunotherapy
Precision Medicine
Lapatinib
Advocacy
Methotrexate
Gail Model
Cachexia
Ki-67 Rate
CMF Chemotherapy
Genetic Predisposition
Physical activity may reduce the risk of breast cancers
Adenocarcinoma
Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
mTOR Inhibitors
Lump
ECOG Score
Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
Alopecia
Staging
1 in 8 women
Family History
Aromatase Inhibitors
Down-Staging
Women ages 40+ should have a clinical breast exam at least yearly
AC Chemotherapy
Tyrosine-Kinase Inhibitor
Bilateral Prophylactic Mastectomy
CAM
Antibody Therapy
Fibroadenoma
PARP Inhibitors
Lumpectomy
Breast Tomosynthesis
Co-survivor
Herceptin
Mastectomy
Hormone Receptor Status
Multifocal Tumors
Biopsy
Tamoxifen
Doxorubicin
Genetic Counseling
FISH
Angiogenesis
Checkpoint Inhibitor
Adjuvant Therapy
Gene Mutation
Progestin
Tumor Grade
LCIS
PI3 Kinase Inhibitors
Relapse
Paget Disease
HER-2
5-Fluorouracil
Lymph Node Status
Pathologic Response
Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year